Atlas Trials

Vaxxinity, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vaxxinity, Inc.

RecordFirmDate
A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered IM in Adult Participants (NCT05762276)Vaxxinity, Inc.2023-03-07
A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants (NCT05477095)Vaxxinity, Inc.2022-07-06
Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine (NCT05293665)Vaxxinity, Inc.2022-03-16
A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine (NCT04683224)Vaxxinity, Inc.2021-02-01

Track Vaxxinity, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.